«Inactive» ingredients in pharmaceutical products: Update (subject review)
American Academy of Pediatrics Committee on Drugs
«Inactive» ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs. Pediatrics 1997; 99: 268-78.
Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-α-tocopheryl polyethylene glycol-1000 succinate
Sokol RJ, Heubi JE, Butler-Simon N et al. Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-α-tocopheryl polyethylene glycol-1000 succinate. Gastroenterology 1987; 93: 975-85.
Carboxyhemoglobin concentration as an index of bilirubin production in neonates with birth weight less than 1,500 grams: A randomized double-blind comparison of supplemental oral vitamin E and placebo
Fischer AF, Inguillo D, Martin DM et al. Carboxyhemoglobin concentration as an index of bilirubin production in neonates with birth weight less than 1,500 grams: a randomized double-blind comparison of supplemental oral vitamin E and placebo. J Pediatr Gastroenterol Nutr 1987; 6: 748-51.
Bilirubin production after supplemental oral vitamin E therapy in preterm infants
Smith DW, Cohen RS, Vreman HJ et al. Bilirubin production after supplemental oral vitamin E therapy in preterm infants. J Pediatr Gastroenterol Nutr 1985; 4: 38-44.
Vitamin E supplementation for prevention of morbidity and mortality in preterm infants
Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. The Cochrane Database of Systematic Reviews 2005, vol. 2.